JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine
Does my patient still need A long-acting inhaler? — PDC Rx
Study design schematic. Abbreviations: LABA, long-actingβ 2 -agonist;... | Download Scientific Diagram
Inhaled long-acting muscarinic antagonists in asthma – A narrative review - ScienceDirect
Understanding the role of long-acting muscarinic antagonists in asthma treatment - ScienceDirect
LAMA - "Long-Acting Muscarinic Antagonists" by AcronymsAndSlang.com
Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease - ScienceDirect
Long-Acting Dual Bronchodilators - LAMA/LABA Combo ... | GrepMed
Study design. Abbreviations: LAMA, long-acting muscarinic antagonist;... | Download Scientific Diagram
Full article: Usage of long-acting muscarinic antagonists and biologics as add-on therapy for patients in the United States with moderate-to-severe asthma
Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
Table 1 from Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar
New developments in inhaled therapy | Practice Nursing
Key findings of recent LAMA and dual-agent LAMA/LABA trials reviewed. | Download Table
Aclidinium: A long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of COPD Stock Photo - Alamy
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chro | JEP
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment | European Respiratory Society
study design. Abbreviations: laBa, long-acting β-2 agonist; laMa,... | Download Scientific Diagram
Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework | Respiratory Research | Full Text
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
Soft-mist LAMA/LABA combination inhaler launched for COPD | MIMS online
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Navigating New Treatment Options for COPD | Consultant360
Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression - Yuji Oba, Nazir A. Lone, 2015
Long-Acting Muscarinic Antagonists (LAMAs) For Asthma
Long-Acting Muscarinic Antagonists - LAMA (Anticholinergic) ... | GrepMed
![PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7a56c4ea6ccc14edcd10985bf0259da67b0b0376/13-Figure1-1.png "PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar")